IFIH1 and interstitial lung disease: In particular cases, the coexistence of anti-Ro52 and anti-MDA5 antibodies has been associated with aggressive and rapidly progressive ILD in anti-MDA5 syndrome (53, 54) but there are conflicting data on the prognostic role of anti-Ro52 antibodies when associated with other MSA (55, 56).